Skip to content

Positive Voices: National Survey of People with HIV

Development and Implementation of Positive Voices: the National Survey of People Living with HIV

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN63267760
Enrollment
1366
Registered
2013-10-11
Start date
2013-07-25
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Infection

Interventions

Incentive, Patients will be randomised to one of four incentive packages in a factorial design: 1. Control - no incentive 2. Offer of health information 3. A prize draw for gift vouchers, or 4. Offe

Sponsors

Public Health England (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Phase 1: Focus Group Discussion & Cognitive Interviews: 1. HIV positive 2. Male and female, aged 18 and over 3. Accessing care at an NHS HIV clinic Phases 2 & 3: Pilot and Full Survey: 1. HIV positive 2. Male and female, aged 18 and over 3. Accessing care at an NHS HIV clinic 4. Reported to SOPHID in the previous calendar year

Exclusion criteria

Exclusion criteria: Phase 1: Focus Group Discussion & Cognitive Interviews: 1. Unable to speak English 2. Participant declines audio recording of the discussion (for focus group discussions only) Phases 2 & 3: Pilot and Full Survey: Unable to complete online questionnaire due to language or literacy

Design outcomes

Primary

MeasureTime frame
Response rates; Timepoints: Which method of incentivising clinics and participants achieves the highest response rate. Assessed at the end of the study. For example, response rates will be calculated by counting the total number of survey responses, the total number of survey invitation slips returned by the clinics, and retrospectively counting the actual number of HIV+ patients who attended during the study period.

Secondary

MeasureTime frame
1. Assess whether response rates among the various risk groups and age groups are representative of the national HIV population (+/10%). 2. Assess key determinants of variation in response rates by risk group, age group, geography, and clinic size. Assessed at the end of the study.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026